Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram D Zuckerman

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Food and Drug Law Journal|August 16, 2005
Challenges in regulating breakthrough medical devicesNeal I Muni, Thomas P Gross, Ashley B Boam, et al.
American Journal of Therapeutics|December 30, 2009
Premarket clinical evaluation of novel cardiovascular devices: quality analysis of premarket clinical studies submitted to the Food and Drug Administration 2000-2007Daniel B Kramer, Elias Mallis, Bram D Zuckerman, et al.
American Heart Journal|May 3, 2005
Coronary drug-eluting stent development: issues in trial designNeal I Muni, Robert M Califf, Jonette R Foy, et al.
JAMA|April 28, 2006
Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reportsWilliam H Maisel, Megan Moynahan, Bram D Zuckerman, et al.
Circulation|October 3, 2002
Drug-eluting stents in preclinical studies: recommended evaluation from a consensus groupRobert S Schwartz, Elazer R Edelman, Andrew Carter, et al.
Health Affairs (Project Hope)|February 4, 2015
Transcatheter valve therapy registry is a model for medical device innovation and surveillanceJohn D Carroll, Jeff Shuren, Tamara Syrek Jensen, et al.
Journal of the American College of Cardiology|December 4, 2020
Early Feasibility Studies for Cardiovascular Devices in the United States: JACC State-of-the-Art ReviewDavid R Holmes, Andrew A Farb, Robert Chip Hance, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 24, 2007
High-risk medical devices, children and the FDA: regulatory challenges facing pediatric mechanical circulatory support devicesChristopher S D Almond, Eric A Chen, Michael R Berman, et al.
Circulation|October 20, 2004
Preclinical evaluation of drug-eluting stents for peripheral applications: recommendations from an expert consensus groupRobert S Schwartz, Elazer R Edelman, Andrew Carter, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Food and Drug Law Journal|August 16, 2005
Challenges in regulating breakthrough medical devicesNeal I Muni, Thomas P Gross, Ashley B Boam, et al.
American Journal of Therapeutics|December 30, 2009
Premarket clinical evaluation of novel cardiovascular devices: quality analysis of premarket clinical studies submitted to the Food and Drug Administration 2000-2007Daniel B Kramer, Elias Mallis, Bram D Zuckerman, et al.
American Heart Journal|May 3, 2005
Coronary drug-eluting stent development: issues in trial designNeal I Muni, Robert M Califf, Jonette R Foy, et al.
JAMA|April 28, 2006
Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reportsWilliam H Maisel, Megan Moynahan, Bram D Zuckerman, et al.
Circulation|October 3, 2002
Drug-eluting stents in preclinical studies: recommended evaluation from a consensus groupRobert S Schwartz, Elazer R Edelman, Andrew Carter, et al.
Health Affairs (Project Hope)|February 4, 2015
Transcatheter valve therapy registry is a model for medical device innovation and surveillanceJohn D Carroll, Jeff Shuren, Tamara Syrek Jensen, et al.
Journal of the American College of Cardiology|December 4, 2020
Early Feasibility Studies for Cardiovascular Devices in the United States: JACC State-of-the-Art ReviewDavid R Holmes, Andrew A Farb, Robert Chip Hance, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 24, 2007
High-risk medical devices, children and the FDA: regulatory challenges facing pediatric mechanical circulatory support devicesChristopher S D Almond, Eric A Chen, Michael R Berman, et al.
Circulation|October 20, 2004
Preclinical evaluation of drug-eluting stents for peripheral applications: recommendations from an expert consensus groupRobert S Schwartz, Elazer R Edelman, Andrew Carter, et al.
Pageof 2